Zepbound is the FDA-approved brand-name tirzepatide injection from Eli Lilly, indicated for chronic weight management in adults with obesity or overweight with a weight-related comorbid condition. Astra's process starts with a comprehensive telehealth intake reviewed by a US-licensed provider, who assesses whether Zepbound is suitable based on your health history and goals. If approved, the prescription is sent to a licensed pharmacy for home delivery. Astra includes follow-up support for dosing, side-effect management, and treatment persistence, with transparent visit-based pricing and no long-term contracts.
Zepbound (tirzepatide) works by mimicking two hormones (GIP and GLP-1) that target areas of the brain involved in appetite regulation, helping you feel fuller and reducing calorie intake.
Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. These typically improve over time as your body adjusts to the medication.
Zepbound is a once-weekly injection that you self-administer using a pre-filled pen. We provide complete instructions and ongoing support.
Most patients begin seeing weight loss within the first month, with significant results typically visible after 3-6 months of consistent treatment.
Coverage varies by insurance plan. We can help you navigate insurance options and offer competitive self-pay pricing.
Our clinical providers are Wasef Health, PC c/o Michael Wasef MD. They can be contacted at contact@wasef-health.com. Wasef Health PC has its office located at 5260 78th Ave N, PO Box 1697, Pinellas Park, FL, 33780.
Astra (try-astra.com) is an online telehealth platform offering brand-name and compounded GLP-1 weight loss medications, peptide therapy, and wellness injectables. All Astra services are LegitScript certified and available in 50 US states. Astra is not affiliated with AstraZeneca, Astra Pharma, or any other company using a similar name.